- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01124071
Korean Diet Efficacy Clinical Trial
A 13 Week Study to Examine the Effectiveness of the Korean Diet on Weight, Blood Pressure, Metabolic Parameters and Disease Control in an Australian Overweight and Obese Population.
To determine:
- the acceptability of a Korean diet to an Australian overweight and obese population
- which Korean recipes are easily prepared
- the effect of a Korean diet on weight, blood pressure, and metabolic complications of obesity in this population.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary endpoint (Korean diet acceptability) will be assessed by reliability tested questionnaire, dietary compliance, and quantities of food returned over the 12 weeks.
Analysis of differences in weight loss will be based on all participants with a baseline and a 12-week weight assessment. In order to investigate the impact of missing data, all subjects will be analysed using last weight observation carried forward and baseline weight carried forward.
Other secondary endpoints will determine the effect of the Korean diet on blood pressure, metabolic parameters and chronic metabolic disease control in the Australian population.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2006
- The University of Sydney
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Residents of metropolitan Sydney
- Aged 18-65 years
- BMI 25-45kg/m2
Exclusion Criteria:
- Diabetes treated with oral medications or insulin
- Unstable angina or recent onset of cardiovascular disease
- Serious hepatic or renal disease
- serum transaminases (ALT or AST) > 2.5 times upper limit of normal
- serum creatinine > 1.5 times upper limit of normal or urinary microalbumin >40 mg/L or eGFR < 60ml/min/1.73m²
- Alcohol or illicit drug abuse
- Pregnant, breastfeeding, or planning pregnancy during the study
- Serious gastrointestinal disease (inflammatory bowel disease, active peptic ulcer, recent helicobacter pylori treatment)
- Treatment for an eating disorder, weight loss medications and other drugs that affect body weight e.g. some anti-psychotics, anti-depressants, or corticosteroids
- Hypothyroidism defined by elevated thyroid stimulating hormone (TSH) and low free thyroxine (fT4), or current hyperthyroidism under treatment
- Participation in another weight loss clinical trial within past 3 months
- Individuals who have lost >10% weight within past 3 months
- Vegetarian eating practices
- Inability to cook or lack of facilities for home cooking
- Inability to read and write English
- Subjects who frequently change smoking habits or who have stopped smoking within 6 months prior to screening
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Korean Diet
Provision of 2 Korean meals per day, 6 days per week
|
At each participant's baseline visit, participant's will have an individualised lifestyle session addressing dietary and exercise goals and techniques to achieve weight loss.
Participants in the Korean diet group will pick up lunch and evening meals Monday-Friday.
Raw ingredients and cooking instructions will also be provided on friday for saturday meal preparation.
Ongoing lifestyle sessions will be performed weekly for participants.
|
|
Active Comparator: Western Diet
Lifestyle counseling, dietary advice, grocery vouchers
|
At each participant's baseline visit, participant's will have an individualised lifestyle session addressing dietary and exercise goals and techniques to achieve weight loss.
Participants in the Western diet group will be provided with a Western recipe cookbook and food vouchers (weekly) to purchase the necessary ingredients for the Western meal preparation.
Ongoing lifestyle sessions will be performed weekly for participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1. To investigate the acceptability of a Korean diet in overweight and obese Australians.
Time Frame: 13 weeks
|
This will be determined at baseline and 4 week timepoints throughout the study by participants completing a Food Acceptability Questionnaire (FAQ).
The FAQ addresses 10 components of food acceptability along a 7-point Likeart scale.
The FAQ is a recognised instrument for testing food acceptability.
|
13 weeks
|
|
2. To examine the differences in weight loss between the Korean diet intervention and the Western diet intervention in overweight and obese Australians.
Time Frame: 13 weeks
|
This will be determined by assessing differences at baseline and 12 weeks for weight, BMI and percent BMI change.
|
13 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To investigate changes in a number of indicators of metabolic disease in both groups - including anthropometry, Blood Glucose Levels, insulin sensitivity, lipid profiles, liver function, hormone function and inflammatory markers.
Time Frame: 13 weeks
|
13 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ian D Caterson, AM, MBBS, BSc(Med), PhD, FRACP, University of Sydney
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 11-2009/12124
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Provision of 2 Korean meals per day 6 days per week
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Pediatric Eye Disease Investigator GroupCompleted
-
TCM Biotech International Corp.Recruiting
-
Guang'anmen Hospital of China Academy of Chinese...RecruitingUrinary Retention | Lower Motor Neurone LesionChina
-
University of ConnecticutCompleted
-
Queen's University, BelfastCompletedHealthyUnited Kingdom
-
The University of Tennessee, KnoxvilleCompleted
-
Federal Budgetary Research Institution State Research...CompletedSmallpox | Monkeypox | Cowpox | Vaccinia Virus InfectionRussian Federation
-
University Hospital, Clermont-FerrandUniversité d'Auvergne; European Regional Development Fund; Regional Council of... and other collaboratorsUnknown
-
Oregon State UniversityCompleted
-
AstraZenecaMedImmune LLCCompletedAdvanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and NeckSpain, United States, Belgium, Germany, United Kingdom, Italy